The combination of psychopharmacology and managed care on the one hand, and
popular images of genetic implications (e.g., the linear linking of individual
genes to specific human characteristics) is creating an economic and cognitive
climate in which complex person/environment arguments will be dismissed as
"unparsimonious."

The current issue of Scientific American has a fascinating article on
pharmacogenetics which never brings environment or experience into view. The
assumption is that people who don't respond to a pharmacological intervention
must have a specific genetic marker which produces that outcome. But why some
genes never get expressed, or issues like apoptosis raised by Schore (that is,
avenues for gene-environment interaction) never get touched.

Someone literate and authoritative should write a letter!